Expert Curated Content

Expert Insights

Curated articles and guides from health and wellness experts. Deep dives into the topics that matter most.

Topic: All Topics ADHD Best Erectile Dysfunction Treatments Best Mattresses Best Testosterone Treatments Best Weight Loss Injections Body Enhancement Botox Diet Plans Hair Loss Home Health Medical Alert Systems NAD+ Anti-aging Sermorelin Telehealth

Featured Expert Articles

Best Weight Loss Injections

Does Ohio Medicaid Cover GLP-1 Weight Loss Drugs in 2026?

Ohio Medicaid covers GLP-1 drugs for type 2 diabetes with prior authorization but excludes them for weight loss in 2026 - here's what to do.

Dr. Marcus Tan, MD Jun 25, 2026
Best Weight Loss Injections

Does AHCCCS (Arizona Medicaid) Cover GLP-1 Weight Loss Drugs in 2026?

AHCCCS covers GLP-1 drugs for type 2 diabetes with prior authorization but excludes weight loss use, with narrow Wegovy exceptions for cardiovascular risk and MASH.

Dr. Marcus Tan, MD Jun 25, 2026
Best Weight Loss Injections

Does Iowa Medicaid Cover GLP-1 Weight Loss Drugs in 2026?

Iowa Medicaid covers GLP-1s for type 2 diabetes with prior authorization but excludes weight loss; Wegovy and Zepbound are covered only for CV-risk, OSA, or MASH.

Dr. Marcus Tan, MD Jun 25, 2026

All Expert Content

3 min read

GLP-1 Drug Interactions: Essential Guide for Weight Loss Patients

GLP-1 receptor agonists like Wegovy, Ozempic, and Zepbound can interact with other medications in ways that affect their effectiveness or safety. Understanding these interactions is crucial for safe and effective weight loss treatment.

Dr. Marcus Tan, MD
3 min read

GLP-1 for Fatty Liver Disease: Evidence & Treatment

Non-alcoholic fatty liver disease (NAFLD) affects up to 30% of adults worldwide and is closely linked to obesity and diabetes. GLP-1 receptor agonists are emerging as powerful treatments that address both weight loss and liver health simultaneously.

Dr. Marcus Tan, MD
4 min read

Monthly Weight Loss Injections 2026: Options & Costs

Monthly weight loss injections represent the next evolution in obesity treatment, offering extended-release formulations that require dosing just once every four weeks. These long-acting medications provide sustained appetite suppression and metabolic benefits while dramatically improving treatment convenience.

Dr. Marcus Tan, MD
3 min read

Weight Loss Medication and Exercise: What Works Best Together

The right exercise approach can boost GLP-1 medication results by 30-40%. Strength training prevents muscle loss, while strategic cardio accelerates fat burning without overwhelming your system.

Dr. Marcus Tan, MD
3 min read

Why GLP-1 Doesn’t Work for Everyone

Up to 20% of patients see minimal weight loss on GLP-1 medications. Genetic factors, medication interactions, and individual biology determine who responds well to these treatments.

Dr. Marcus Tan, MD
2 min read

Foundayo (Orforglipron) Complete Guide: Eli Lilly’s GLP-1 Pill

Foundayo hit the market in April 2026 as the first non-peptide GLP-1 pill without food restrictions. Unlike other oral weight loss medications, you can take Foundayo with meals, water, or any time of day.

Dr. Marcus Tan, MD
3 min read

GLP-1 for Heart Health: Cardiovascular Benefits 2026

GLP-1 medications now carry FDA approval for reducing major cardiovascular events, not just weight loss. The SELECT trial results changed how doctors prescribe these medications for patients with heart disease risk.

Dr. Marcus Tan, MD
3 min read

Ozempic Face and Body Changes on GLP-1 Medication

"Ozempic face" describes facial aging that can occur during rapid weight loss on GLP-1 medications. This cosmetic side effect results from volume loss in facial fat, not the medication itself.

Dr. Marcus Tan, MD
2 min read

Retatrutide: The Triple Agonist Weight Loss Drug Coming Soon

Retatrutide represents the next frontier in obesity treatment. This investigational triple-receptor agonist from Eli Lilly targets GLP-1, GIP, and glucagon receptors simultaneously, delivering unprecedented weight loss results in clinical trials.

Dr. Marcus Tan, MD
2 min read

Wegovy 7.2mg: The New High-Dose Semaglutide for 2026

The FDA approved Wegovy 7.2mg in March 2026, marking the highest-dose semaglutide treatment available for weight management. This new formulation delivers unprecedented weight loss results for patients who need maximum intervention.

Dr. Marcus Tan, MD
3 min read

Can You Take GLP-1 Medication Long Term?

Yes, most patients can take GLP-1 medications long term. Obesity is a chronic medical condition requiring ongoing treatment, similar to diabetes or high blood pressure. Clinical studies show continued safety and effectiveness for 5+ years.

Dr. Marcus Tan, MD
4 min read

Do GLP-1 Drugs Cause Hair Loss?

GLP-1 medications don't directly cause hair loss, but rapid weight loss can trigger telogen effluvium—temporary hair thinning that affects 10-25% of patients. This usually resolves within 6-12 months with proper support.

Dr. Marcus Tan, MD